• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白原对隐静脉的血管活性作用。

Vasoactive effects of fibrinogen on saphenous vein.

作者信息

Hicks R C, Golledge J, Mir-Hasseine R, Powell J T

机构信息

Cardiovascular & Pulmonary Research Division, Charing Cross & Westminster Medical School, London, UK.

出版信息

Nature. 1996 Feb 29;379(6568):818-20. doi: 10.1038/379818a0.

DOI:10.1038/379818a0
PMID:8587603
Abstract

Normal plasma fibrinogen concentrations are critical to haemostasis. Higher fibrinogen concentrations are associated with increasing risk of atherosclerotic disease and with graft stenosis and occlusion after saphenous vein bypass surgery. Vein graft stenosis is characterized by the localized proliferation of intimal smooth muscle cells, causing narrowing of the graft with increased risk of thrombotic occlusion. In rabbit arteries, fibrinopeptide B is reported to have both vasoconstrictor and mitogenic properties. We report here that fibrinopeptides had no vasoactive effects on saphenous vein rings; however, fibrinogen (0-2 microM) affected an endothelium-dependent relaxation, followed by recontraction at higher concentrations. The fibrinogen-mediated relaxation was inhibited by K+-channel blockers and antibodies to ICAM-1. Coupled signalling pathways for the synthesis of vasoactive mediators and mitogens could underlie the association between fibrinogen and the development of vein graft pathology.

摘要

正常的血浆纤维蛋白原浓度对止血至关重要。较高的纤维蛋白原浓度与动脉粥样硬化疾病风险增加以及大隐静脉搭桥手术后的移植物狭窄和闭塞有关。静脉移植物狭窄的特征是内膜平滑肌细胞局部增殖,导致移植物狭窄,血栓形成闭塞风险增加。据报道,在兔动脉中,纤维蛋白肽B具有血管收缩和促有丝分裂特性。我们在此报告,纤维蛋白肽对大隐静脉环没有血管活性作用;然而,纤维蛋白原(0-2 microM)影响内皮依赖性舒张,在较高浓度时随后出现再收缩。纤维蛋白原介导的舒张被钾通道阻滞剂和抗ICAM-1抗体抑制。血管活性介质和促有丝分裂原合成的耦合信号通路可能是纤维蛋白原与静脉移植物病理发展之间关联的基础。

相似文献

1
Vasoactive effects of fibrinogen on saphenous vein.纤维蛋白原对隐静脉的血管活性作用。
Nature. 1996 Feb 29;379(6568):818-20. doi: 10.1038/379818a0.
2
Circumferential deformation and shear stress induce differential responses in saphenous vein endothelium exposed to arterial flow.周向变形和剪切应力在暴露于动脉血流的大隐静脉内皮中引发不同反应。
J Clin Invest. 1997 Jun 1;99(11):2719-26. doi: 10.1172/JCI119461.
3
Arterial flow induces changes in saphenous vein endothelium proteins transduced by cation channels.动脉血流会引起由阳离子通道转导的隐静脉内皮细胞蛋白发生变化。
Eur J Vasc Endovasc Surg. 2000 May;19(5):545-50. doi: 10.1053/ejvs.1999.1059.
4
Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells.纤维蛋白原上调人隐静脉内皮细胞中单核细胞趋化蛋白1的表达。
Biochem J. 1999 Aug 1;341 ( Pt 3)(Pt 3):739-44.
5
Fibrin monomer and fibrinopeptide B act additively to increase DNA synthesis in smooth muscle cells cultured from human saphenous vein.纤维蛋白单体和纤维蛋白肽B共同作用可增加从人隐静脉培养的平滑肌细胞中的DNA合成。
J Vasc Surg. 2001 Apr;33(4):847-53. doi: 10.1067/mva.2001.111984.
6
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit.抗血管生成药物利诺胺对兔主动脉和隐静脉制剂的血管舒张作用。
Br J Pharmacol. 1997 Dec;122(8):1739-45. doi: 10.1038/sj.bjp.0701565.
7
Risk factors of atherosclerosis and saphenous vein endothelial function.动脉粥样硬化和隐静脉内皮功能的危险因素。
Int Angiol. 2001 Jun;20(2):152-63.
8
Neutrophil adherence to activated saphenous vein and mammary endothelium after graft preparation.移植准备后中性粒细胞对活化的大隐静脉和乳腺内皮的黏附。
Ann Thorac Surg. 2006 Apr;81(4):1262-8. doi: 10.1016/j.athoracsur.2005.09.073.
9
Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein.内皮素-1是人体大隐静脉器官培养中内膜增生的介质。
Br J Surg. 1997 Apr;84(4):499-503.
10
Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.3条人类旁路血管的血管壁重塑:器官培养和平滑肌细胞特性
J Thorac Cardiovasc Surg. 2006 Mar;131(3):651-8. doi: 10.1016/j.jtcvs.2005.08.048.

引用本文的文献

1
The emerging role of fibrin(ogen) in cardiovascular disease.纤维蛋白(原)在心血管疾病中的新作用。
Inflamm Res. 2024 Sep;73(9):1435-1444. doi: 10.1007/s00011-024-01916-2. Epub 2024 Jul 18.
2
Correlation and risk factors of peripheral and cervicocephalic arterial atherosclerosis in patients with ischemic cerebrovascular disease.缺血性脑血管病患者外周和颈颅动脉粥样硬化的相关性及危险因素。
Sci Rep. 2024 May 23;14(1):11773. doi: 10.1038/s41598-024-62092-1.
3
Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease.
纤维蛋白原与血栓形成、炎症和肾素-血管紧张素系统三联征在女性早发冠心病中的作用:对疾病发病机制中性别差异的新认识。
Biomolecules. 2021 Jul 15;11(7):1036. doi: 10.3390/biom11071036.
4
Fibrinogen-induced increased pial venular permeability in mice.纤维蛋白原诱导小鼠脑膜微血管通透性增加。
J Cereb Blood Flow Metab. 2012 Jan;32(1):150-63. doi: 10.1038/jcbfm.2011.144. Epub 2011 Oct 12.
5
Fibrinogen and left ventricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA).纤维蛋白原与左心室心肌收缩功能:动脉粥样硬化多民族研究(MESA)。
Am Heart J. 2010 Sep;160(3):479-86. doi: 10.1016/j.ahj.2010.06.001.
6
Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease.纤维蛋白原在心血管疾病期间导致微血管功能障碍的机制。
Acta Physiol (Oxf). 2010 Jan;198(1):1-13. doi: 10.1111/j.1748-1716.2009.02037.x. Epub 2009 Sep 1.
7
Involvement of fibrinogen specific binding in erythrocyte aggregation.纤维蛋白原特异性结合在红细胞聚集中的作用。
FEBS Lett. 2002 Apr 24;517(1-3):41-4. doi: 10.1016/s0014-5793(02)02575-9.
8
Fibrinogen and coronary risk.纤维蛋白原与冠心病风险。
Curr Cardiol Rep. 1999 Jul;1(2):112-8. doi: 10.1007/s11886-999-0068-y.
9
Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells.纤维蛋白原上调人隐静脉内皮细胞中单核细胞趋化蛋白1的表达。
Biochem J. 1999 Aug 1;341 ( Pt 3)(Pt 3):739-44.
10
Circumferential deformation and shear stress induce differential responses in saphenous vein endothelium exposed to arterial flow.周向变形和剪切应力在暴露于动脉血流的大隐静脉内皮中引发不同反应。
J Clin Invest. 1997 Jun 1;99(11):2719-26. doi: 10.1172/JCI119461.